http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019524834-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019524834-A |
| titleOfInvention | Treatment of developmental disorders with biguanides |
| abstract | Biguanides, eg, metformin, buformin, phenformin, or pharmaceutically acceptable salts thereof, Angelman syndrome, fragile X syndrome, fragile X-related tremor / ataxia syndrome (FXTAS), autism spectrum disorder, self Developmental disorders such as autism, Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, Rett syndrome, Landau-Krefner syndrome, Prader-Willi syndrome, late-onset dyskinesia, epileptic seizure disorder, and / or Williams syndrome A method of treatment is provided. The method provides a therapeutic composition used to ameliorate one or more symptoms of the developmental disorder. [Selection figure] None |
| priorityDate | 2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 247.